Posted by Marty on September 3, 2008, at 14:24:25
In reply to Re: hm: and aglomelatine is ) venlafaxine too, posted by Negcreep on September 3, 2008, at 9:29:28
> Brilliant news, still hanging on for news from the EMEA on this one. They usually put out a monthly report on their website in the first week of each month....I'm hoping agomelatine is approved :)
---
I knew you'd like that news Neg :)Since Dr.Kasper(sp?) is an adviser of EMEA and on the approval commitee and since the EMEA concern wasn't about the safety but about the efficacy, I think it's now safe to expect Valdoxan to be approve in the next couple months.
That said I doubt it will be marketed this month or even the next. But I, for one, can wait as now I feel much better waiting for it knowing it WILL BE marketed. Nothing stands in the way of an European release now.BTW, I find it quite funny that the study has been financed by Servier and that the main investigator, Dr.Kasper, is on the EMEA approval board ! .. Could you imagine that in the US ? Glaxo Smith Kline, in the 90's, financing a trial for Paxil in which the responsible of the trial is on the approval board of the FDA !? .. that would be one HUGE scandal. Well, it seems to be good practice in Europe and that's just flabbergasting.
/\/\arty
poster:Marty
thread:849952
URL: http://www.dr-bob.org/babble/20080903/msgs/850093.html